Evaluation of vitamin D3, calcium and parathyroid hormone among women with osteoporosis in Wasit Province, Iraq

https://doi.org/10.53730/ijhs.v6nS5.9466

Authors

  • Suhad S. Ali Department of Biology, College of Science, University of Wasit, Wasit, Iraq
  • Mohammed R. S. AL-Attabi Department of Biology, College of Science, University of Wasit, Wasit, Iraq

Keywords:

Osteoporosis, Vitamin D3, Calcium, Parathyroid hormone

Abstract

Background: Osteoporosis (OP) is one of the most common metabolic diseases, characterized by low bone mass and abnormal bone microarchitecture leading to the development of fractures and subsequent disability. Disruption of bone remodeling by osteoporosis results in an imbalance between bone formation by osteoblasts and resorption by osteoclasts. Aims: This study was aimed to investigate relationship between vitamin D3, calcium and PTH, with estimating their effects on osteoporosis in women and the benefits in diagnosis. Materials and method: In this study, 50women who were referred to DEXA unit in Al-Karama Teaching Hospital to diagnosed with Osteoporosis. They were compared with 40 healthy individuals who did not have any clinical symptoms. Blood samples were used after separating them by a centrifuge for the purpose of examining levels of vital indicators were detected by Enzyme linked immunosorbent assay (ELISA). Results: The results of the current study showed a decrease in the level of Vitamin D3 and calcium, increasing in the levels of Parathyroid hormone, with significant differences between the study groups at P≤0.0001 compared to the control group.

Downloads

Download data is not yet available.

References

Si, J., Wang, C., Zhang, D., Wang, B., Hou, W., and Zhou, Y. (2020). Osteopontin in bone metabolism and bone diseases. Medical science monitor: international medical journal of experimental and clinical research, 26, e919159-1.‏

Sözen, T., Özışık, L., andBaşaran, N. Ç. (2017). An overview and management of osteoporosis. European journal of rheumatology, 4(1), 46.‏

Wu, Q. Y., Li, X., Miao, Z. N., Ye, J. X., Wang, B., Zhang, F., ... and Yuan, F. L. (2018). Long non-coding RNAs: a new regulatory code for osteoporosis. Frontiers in Endocrinology, 587.‏

Ge, D. W., Wang, W. W., Chen, H. T., Yang, L., and Cao, X. J. (2017). Functions of microRNAs in osteoporosis. Eur Rev Med PharmacolSci, 21(21), 4784-9.‏

Kadam, N. S., Chiplonkar, S. A., Khadilkar, A. V., andKhadilkar, V. V. (2018). Prevalence of osteoporosis in apparently healthy adults above 40 years of age in Pune City, India. Indian journal of endocrinology and metabolism, 22(1), 67.‏

Chapurlat, R. D. (2015). Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women. Therapeutic advances in musculoskeletal disease, 7(3), 103-109.‏

Hsu, T. L., Tantoh, D. M., Chou, Y. H., Hsu, S. Y., Ho, C. C., Lung, C. C., ... andLiaw, Y. P. (2020). Association between osteoporosis and menopause in relation to SOX6 rs297325 variant in Taiwanese women. Menopause (New York, NY), 27(8), 887.‏

Bolarin, D. M., Ekpe, E. L., Saidu, K., andEyam, E. S. (2016). A glance at biomarkers of bone metabolism. Pakistan Journal of Nutrition, 15(5), 499.‏

Ali, N. K. (2018). Estimation of some mineral (calcium, phosphorous, vitamin 25 (OH) D and alkaline phosphatase) in osteoporosis patients in Kirkuk city. J Osteopor Phys Act, 6(2).‏‏

14. Regan LB, Kevin WD, Joseph AG, Jaime JC, Johanna TD, et al. (2010) Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 140: 817-822.

Silva, B. C., & Bilezikian, J. P. (2015). Parathyroid hormone: anabolic and catabolic actions on the skeleton. Current opinion in pharmacology, 22, 41-50.‏

Khedr, A. (2018). Skeletal manifestations of hyperparathyroidism. In Anatomy, Posture, Prevalence, Pain, Treatment and Interventions of Musculoskeletal Disorders. IntechOpen.‏

Nakamura, Y., Suzuki, T., Kamimura, M., Murakami, K., Ikegami, S., Uchiyama, S., and Kato, H. (2017). Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment. Bone Research, 5(1), 1-7.‏

Albrahim, T. I., andBinobead, M. A. (2019). Vitamin D status in relation to age, bone mineral density of the spine and femur in obese Saudi females–A hospital-based study. Saudi Pharmaceutical Journal, 27(2), 200-207.‏

Nair, R., Maseeh, A., and Vitamin, D. J. (2012). PharmacolPharmacother. The “sunshine” vitamin, 3, 118-126.‏

Narula, R., Tauseef, M., Ahmad, I. A., Agarwal, K., Ashok, A., andAnjana, A. (2013). Vitamin D deficiency among postmenopausal women with osteoporosis. Journal of Clinical and Diagnostic Research: JCDR, 7(2), 336.‏

Pardhe, B. D., Pathak, S., Bhetwal, A., Ghimire, S., Shakya, S., Khanal, P. R., andMarahatta, S. B. (2017). Effect of age and estrogen on biochemical markers of bone turnover in postmenopausal women: a population-based study from Nepal. International journal of women's health, 9, 781.‏

Akkawi, I., andZmerly, H. (2018). Osteoporosis: current concepts. Joints, 6(02), 122-127.‏

Wahyuni, S., Chalid, S. M. T., Pelupessy, N. U., Arifuddin, S., Idris, I., & Usman, A. N. (2022). Comparison of the use of shock index and modified early obstetric warning score in COVID-19 obstetric emergency patients as ICU care parameters. International Journal of Health & Medical Sciences, 5(1), 80-90. https://doi.org/10.21744/ijhms.v5n1.1844

Hamdi, R. A. (2013). Evaluation of Serum Osteocalcin level in Iraqi Postmenopausal women with primary osteoporosis. Journal of the Faculty of Medicine Baghdad, 55(2), 166-169.‏

Shukla, A., Dasgupta, N., Ranjan, S., Singh, S., andChidambram, R. (2017). Nanotechnology towards prevention of anaemia and osteoporosis: from concept to market. Biotechnology and Biotechnological Equipment, 31(5), 863-879.‏

Ponnapakkam, T., Katikaneni, R., Sakon, J., Stratford, R., andGensure, R. C. (2014). Treating osteoporosis by targeting parathyroid hormone to bone. Drug discovery today, 19(3), 204-208.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Bhattarai, H. K., Shrestha, S., Rokka, K., andShakya, R. (2020). Vitamin D, calcium, parathyroid hormone, and sex steroids in bone health and effects of aging. Journal of osteoporosis, 2020.‏ ‏

Khedr, A. (2018). Skeletal manifestations of hyperparathyroidism. In Anatomy, Posture, Prevalence, Pain, Treatment and Interventions of Musculoskeletal Disorders. IntechOpen.‏

Martins, J. S., Palhares, M. D. O., Teixeira, O. C. M., andGontijo Ramos, M. (2017). Vitamin D status and its association with parathyroid hormone concentration in Brazilians. Journal of nutrition and metabolism, 2017.‏

Published

22-06-2022

How to Cite

Ali, S. S., & AL-Attabi, M. R. S. (2022). Evaluation of vitamin D3, calcium and parathyroid hormone among women with osteoporosis in Wasit Province, Iraq. International Journal of Health Sciences, 6(S5), 3907–3913. https://doi.org/10.53730/ijhs.v6nS5.9466

Issue

Section

Peer Review Articles